MBAI
Check-Cap Ltd.
$8.04
+0.25%
2026-08-21
About Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
Key Fundamentals
P/E Ratio
1.89
EPS (TTM)
$4.62
ROE
416.7%
Profit Margin
0.0%
Debt/Equity
0.47
Price/Book
17.80
Beta
0.82
Market Cap
$11.8M
Avg Volume (10D)
27K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$10.21
60D Low
$0.97
Avg Volume
57K
Latest Close
$8.04
Get breakout alerts for MBAI
Sign up for Breakout Scanner to receive daily notifications when MBAI triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Check-Cap Ltd. (MBAI) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors MBAI daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. MBAI operates in the Healthcare sector within the Diagnostics & Research industry. Data is provided for informational purposes only and does not constitute financial advice.